MINERVAX APS has a total of 12 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are TECHNICLONE INC, WNTRESEARCH AB and ADC THERAPEUTICS SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 | |
#6 | Hungary | 1 | |
#7 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Pedersen Fischer Per Bo | 6 |
#2 | Pedersen Per Bo | 3 |
#3 | Lindahl Gunnar | 3 |
Publication | Filing date | Title |
---|---|---|
US2019282681A1 | Immunogenic complex for eliciting protective immunity against group b streptococcus | |
CA3001433A1 | Immunogenic fusion protein | |
HUE028253T2 | Fusion protein vaccine |